Opinion|Videos|February 14, 2024
Utilizing Real-World Data for Informed Decision-Making in CLL
Sikander Ailawadhi, MD, review real-world data findings recently presented at ASH 2023, highlighting their potential implications on the treatment landscape.
Advertisement
Utilizing Real-World Data for Informed Decision-Making in CLL
Episodes in this series
Advertisement
Related to this article
Oral vitamin C improved OS in patients with CCUS or lower-risk myeloid malignancies in the EVITA trial despite missing the clonal growth primary end point.
Advertisement
Advertisement
Trending on CancerNetwork
1
Prior Regimen Did Not Affect Daraxonrasib Benefit in Pretreated Pancreatic Cancer
2
Petosemtamab/Pembrolizumab Improves OS in First-Line PD-L1–Positive HNSCC
3
Sacituzumab Govitecan PFS Benefit Holds Across Subgroups in Untreated mTNBC
4
What Are the Top Takeaways for Neuroendocrine Carcinoma From 2026 ESMO?
5